(Q77706035)
Statements
Randomized controlled trial of single-agent paclitaxel versus cyclophosphamide, doxorubicin, and cisplatin in patients with recurrent ovarian cancer who responded to first-line platinum-based regimens (English)
M G Cantù
A Buda
G Parma
R Rossi
I Floriani
C Bonazzi
T Dell'Anna
V Torri